Gilman Hill Asset Management LLC Has $694,000 Stake in Merck & Company, Inc. (MRK)

Gilman Hill Asset Management LLC reduced its holdings in shares of Merck & Company, Inc. (NYSE:MRK) by 5.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,836 shares of the company’s stock after selling 624 shares during the quarter. Gilman Hill Asset Management LLC’s holdings in Merck & were worth $694,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. HM Capital Management LLC lifted its holdings in shares of Merck & by 2.4% during the second quarter. HM Capital Management LLC now owns 3,825 shares of the company’s stock valued at $245,000 after purchasing an additional 91 shares in the last quarter. OLD Second National Bank of Aurora lifted its holdings in shares of Merck & by 2.5% during the second quarter. OLD Second National Bank of Aurora now owns 39,101 shares of the company’s stock valued at $2,506,000 after purchasing an additional 939 shares in the last quarter. Berkshire Asset Management LLC PA lifted its holdings in shares of Merck & by 2.1% during the second quarter. Berkshire Asset Management LLC PA now owns 188,161 shares of the company’s stock valued at $12,059,000 after purchasing an additional 3,913 shares in the last quarter. Breton Hill Capital Ltd. lifted its holdings in shares of Merck & by 34.6% during the second quarter. Breton Hill Capital Ltd. now owns 60,559 shares of the company’s stock valued at $3,881,000 after purchasing an additional 15,578 shares in the last quarter. Finally, Investment Partners Ltd. OH ADV lifted its holdings in shares of Merck & by 0.9% during the second quarter. Investment Partners Ltd. OH ADV now owns 14,800 shares of the company’s stock valued at $949,000 after purchasing an additional 127 shares in the last quarter. 73.02% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts have recently issued reports on MRK shares. Jefferies Group LLC reaffirmed a “sell” rating and set a $51.00 price target on shares of Merck & in a report on Wednesday, May 24th. Zacks Investment Research downgraded Merck & from a “buy” rating to a “hold” rating in a report on Thursday, May 25th. BMO Capital Markets reissued a “buy” rating and issued a $74.00 target price on shares of Merck & in a report on Tuesday, June 6th. Credit Suisse Group set a $72.00 target price on Merck & and gave the company a “buy” rating in a report on Tuesday, June 6th. Finally, BidaskClub raised Merck & from a “sell” rating to a “hold” rating in a report on Thursday, June 22nd. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $70.00.

ILLEGAL ACTIVITY WARNING: “Gilman Hill Asset Management LLC Has $694,000 Stake in Merck & Company, Inc. (MRK)” was first reported by BBNS and is the property of of BBNS. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/merck-company-inc-mrk-shares-sold-by-gilman-hill-asset-management-llc/1605176.html.

Shares of Merck & Company, Inc. (NYSE MRK) traded down 0.340% during mid-day trading on Friday, reaching $65.895. The company’s stock had a trading volume of 8,167,589 shares. The firm has a market cap of $179.72 billion, a P/E ratio of 35.677 and a beta of 0.81. The firm’s 50-day moving average price is $63.34 and its 200 day moving average price is $63.72. Merck & Company, Inc. has a 12-month low of $58.29 and a 12-month high of $66.80.

Merck & (NYSE:MRK) last posted its quarterly earnings results on Friday, July 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.14. The business had revenue of $9.93 billion during the quarter, compared to analyst estimates of $9.75 billion. Merck & had a return on equity of 26.02% and a net margin of 17.14%. The business’s revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.93 earnings per share. On average, analysts expect that Merck & Company, Inc. will post $3.87 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 6th. Stockholders of record on Friday, September 15th will be given a $0.47 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.84%. Merck &’s dividend payout ratio (DPR) is presently 76.11%.

About Merck &

Merck & Co, Inc is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures.

Institutional Ownership by Quarter for Merck & (NYSE:MRK)

Receive News & Ratings for Merck & Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Company Inc. and related companies with our FREE daily email newsletter.

 


Latest News

New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Dodgers End Losing Streak at 11 Behind Ace Clayton Kershaw
Dodgers End Losing Streak at 11 Behind Ace Clayton Kershaw


Leave a Reply

 
© 2006-2017 BBNS.